Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Drug	O
Allergies	O
/	O
Lactose	O
/	O
Gluten	O
Attending:	O
___.	O
Chief	O
Complaint:	O
elevated	O
potassium,	O
fatigue	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
y/o	O
female	O
with	O
a	O
h/o	O
rheumatoid	O
arthritis,	O
atuoimmune	O
hepatitis	O
s/p	O
transplant,	O
HTN,	O
hypertriglyceridemia,	O
depression	O
who	O
prseented	O
to	O
the	O
ED	O
when	O
outpatient	O
labs	O
revealed	O
elevated	O
potassium	O
and	O
creatinine.	O
The	O
patient	O
was	O
recently	O
started	O
on	O
ACE-I	O
approximately	O
one	O
month	O
ago	O
by	O
cardiology	O
(not	O
in	O
BI	O
system).	O
The	O
patient	O
reports	O
that	O
generally	O
she	O
has	O
felt	O
tired	O
and	O
fatigued.	O
She	O
also	O
reports	O
dysuria	O
x	O
2	O
-	O
3	O
days	O
and	O
increased	O
urinary	O
frequency.	O
No	O
urgency,	O
fever,	O
chills,	O
different	O
back	O
pain,	O
or	O
abdominal	O
pain.	O
In	O
the	O
ED,	O
initial	O
vitals	O
were	O
96.4	O
62	O
137/38	O
18	O
100%	O
ra.	O
Labs	O
notable	O
for	O
hyperkalemia	O
to	O
6.1,	O
worsening	O
creatinine	O
to	O
1.9	O
from	O
baseline	O
of	O
1.3.	O
Currently,	O
the	O
patient	O
reports	O
that	O
she	O
feels	O
well.	O
She	O
feels	O
tired	O
though.	O
No	O
CP,	O
SOB,	O
palpitations.	O
No	O
anuria.	O
ROS:	O
as	O
per	O
HPI	O
and	O
below	O
-	O
positve	O
for	O
headache	O
last	O
night	O
___	O
spontaneously	O
resolved	O
positive	O
for	O
chronic	O
back	O
pain	O
positive	O
for	O
depressed	O
mood	O
positive	O
for	O
gas	O
pains	O
denies	O
fever,	O
chills,	O
night	O
sweats,	O
vision	O
changes,	O
rhinorrhea,	O
congestion,	O
sore	O
throat,	O
cough,	O
shortness	O
of	O
breath,	O
chest	O
pain,	O
abdominal	O
pain,	O
nausea,	O
vomiting,	O
diarrhea,	O
constipation,	B-Constipation
BRBPR,	B-Lower_gastrointestinal_haemorrhage
melena,	B-Upper_gastrointestinal_haemorrhage
hematochezia,	B-Lower_gastrointestinal_haemorrhage
hematuria.	O
Past	O
Medical	O
History:	O
Autoimmune	O
hepatitis/cirrhosis,	O
diagnoed	O
___	O
yrs	O
ago	O
with	O
bx	O
in	O
___,	O
complicated	O
by	O
varices	O
-	O
s/p	O
liver	O
transplant	O
Alloimmune	O
hepatitis	O
Diabetes	O
Type	O
2,	O
with	O
nephropathy	O
h/o	O
breast	O
lump	O
hypertension	O
hypertriglyceridemia	O
depression	O
rheumatoid	O
arthritis	O
h/o	O
shingles	O
reflux	O
B12	O
def	O
Vit	O
D	O
def	O
cholecystectomy	O
appendectomy	O
Bladder	O
prolapse	O
repair	O
___	O
ERCP,	O
sphincterotomy,	O
stent	O
placement	O
Social	O
History:	O
___	O
Family	O
History:	O
mother-	O
stomach	O
problems,	O
heart	O
disease	O
mGM-	O
stomach	O
problems	O
does	O
not	O
know	O
fathers	O
medical	O
history	O
Cousin	O
-	O
liver	O
disease,	O
did	O
not	O
require	O
transplant	O
Physical	O
Exam:	O
Physical	O
Exam	O
on	O
Admission:	O
VS	O
-	O
T	O
98.4,	O
BP	O
116/50,	O
HR	O
54,	O
RR	O
17,	O
98%	O
on	O
RA	O
GENERAL	O
-	O
well-appearing	O
female	O
in	O
NAD,	O
comfortable,	O
appropriate	O
HEENT	O
-	O
NC/AT,	O
PERRLA,	O
EOMI,	O
sclerae	O
anicteric,	O
MMM,	O
OP	O
clear	O
NECK	O
-	O
supple,	O
no	O
thyromegaly,	O
no	O
JVD	O
LUNGS	O
-	O
CTA	O
bilat,	O
no	O
r/rh/wh,	O
good	O
air	O
movement,	O
resp	O
unlabored,	O
no	O
accessory	O
muscle	O
use	O
HEART	O
-	O
RRR,	O
no	O
MRG,	O
nl	O
S1-S2	O
ABDOMEN	O
-	O
NABS,	O
soft/ND,	O
mildly	O
tender	O
throughout,	O
no	O
masses	O
or	O
HSM,	O
no	O
rebound/guarding,	O
scar	O
present	O
Back	O
-	O
no	O
CVA	O
tenderness	O
EXTREMITIES	O
-	O
WWP,	O
no	O
c/c/e,	O
2+	O
peripheral	O
pulses	O
(radials,	O
DPs)	O
SKIN	O
-	O
no	O
rashes	O
or	O
lesions	O
NEURO	O
-	O
awake,	O
A&Ox3,	B-Delirium
CNs	O
II-XII	O
grossly	O
intact,	O
muscle	O
strength	O
___	O
throughout,	O
sensation	O
grossly	O
intact	O
throughout	O
Physical	O
Exam	O
on	O
Discharge:	O
VS	O
-	O
97.8,	O
104/91,	O
61,	O
18,	O
98%	O
RA	O
GENERAL	O
-	O
well-appearing	O
female	O
in	O
NAD,	O
comfortable,	O
appropriate	O
HEENT	O
-	O
NC/AT,	O
PERRL,	O
EOMI,	O
sclerae	O
anicteric,	O
MMM,	O
OP	O
clear	O
NECK	O
-	O
supple,	O
no	O
thyromegaly,	O
no	O
JVD	O
LUNGS	O
-	O
CTA	O
bilat,	O
no	O
r/rh/wh,	O
good	O
air	O
movement,	O
resp	O
unlabored,	O
no	O
accessory	O
muscle	O
use	O
HEART	O
-	O
RRR,	O
no	O
MRG,	O
nl	O
S1-S2	O
ABDOMEN	O
-	O
NABS,	O
soft/ND,	O
mildly	O
tender	O
throughout,	O
no	O
masses	O
or	O
HSM,	O
no	O
rebound/guarding,	O
scar	O
present	O
EXTREMITIES	O
-	O
WWP,	O
no	O
c/c/e,	O
2+	O
peripheral	O
pulses	O
(radials,	O
DPs)	O
SKIN	O
-	O
no	O
rashes	O
or	O
lesions	O
NEURO	O
-	O
awake,	O
A&Ox3,	B-Delirium
CNs	O
II-XII	O
grossly	O
intact,	O
muscle	O
strength	O
___	O
throughout,	O
sensation	O
grossly	O
intact	O
throughout	O
Pertinent	O
Results:	O
Labs	O
on	O
Admission:	O
___	O
12:25AM	O
BLOOD	O
WBC-4.7	O
RBC-3.21*	O
Hgb-10.3*	O
Hct-30.7*	O
MCV-96#	O
MCH-32.1*	O
MCHC-33.6	O
RDW-16.5*	O
Plt	O
___	O
___	O
06:18AM	O
BLOOD	O
___	O
PTT-49.2*	O
___	O
___	O
12:25AM	O
BLOOD	O
Glucose-113*	O
UreaN-48*	O
Creat-1.9*	O
Na-139	O
K-6.1*	O
Cl-109*	O
HCO3-18*	O
AnGap-18	O
___	O
06:18AM	O
BLOOD	O
ALT-11	O
AST-18	O
LD(LDH)-128	O
AlkPhos-120*	O
TotBili-0.3	O
___	O
01:40PM	O
BLOOD	O
Calcium-8.9	O
Phos-4.2	O
Mg-2.1	O
Other	O
Labs:	O
___	O
06:18AM	O
BLOOD	O
tacroFK-8.7	O
Labs	O
on	O
Discharge:	O
___	O
05:25AM	O
BLOOD	O
Glucose-84	O
UreaN-44*	O
Creat-1.8*	O
Na-138	O
K-5.7*	O
Cl-112*	O
HCO3-15*	O
AnGap-17	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
is	O
a	O
___	O
y/o	O
female	O
with	O
a	O
h/o	O
rheumatoid	O
arthritis,	O
atuoimmune	O
hepatitis	O
s/p	O
transplant,	O
HTN,	O
hypertriglyceridemia,	O
depression	O
who	O
prseented	O
to	O
the	O
ED	O
when	O
outpatient	O
labs	O
revealed	O
elevated	O
potassium	O
and	O
creatinine.	O
The	O
patient	O
also	O
found	O
to	O
have	O
a	O
UTI.	B-Urinary_tract_infection
Acute	O
Issues:	O
#	O
Hyperkalemia	O
and	O
Acute	O
on	O
Chronic	O
Kidney	O
Disease:	O
Likely	O
secondary	O
to	O
recent	O
start	O
of	O
lisinopril.	O
Patient	O
with	O
K+	O
of	O
5.9	O
on	O
admission	O
and	O
Cr	O
of	O
1.9	O
(baseline	O
Cr	O
throughout	O
___	O
1.1	O
-	O
1.6).	O
Patient	O
also	O
with	O
elevated	O
tacrolimus	O
level	O
at	O
___	O
labratory	O
as	O
an	O
outpatient,	O
which	O
could	O
also	O
contribute	O
to	O
hyperkalemia.	O
The	O
patient's	O
potassium	O
initially	O
increased	O
to	O
6.5.	O
She	O
was	O
then	O
given	O
one	O
dose	O
of	O
kayexalate	O
and	O
started	O
on	O
HCTZ.	O
She	O
was	O
monitored	O
on	O
telemetry	O
and	O
had	O
repeat	O
EKG	O
preformed.	O
The	O
patient	O
had	O
no	O
changes	O
on	O
EKG	O
and	O
no	O
signs	O
of	O
hyperkalemia	O
detected	O
on	O
tele	O
or	O
EKG.	O
The	O
patient	O
had	O
a	O
K+	O
of	O
5.7	O
on	O
day	O
of	O
discharge.	O
#	O
UTI:	O
Patient	O
with	O
dysuria	O
and	O
UA	O
showeing	O
131	O
WBCs	O
and	O
many	O
bacteria	O
consistent	O
with	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
Afebrile,	O
without	O
N/V,	O
flank	O
pain.	O
She	O
was	O
treated	O
with	O
ciprofloxacin	O
x	O
3	O
days.	O
Chronic	O
Issues:	O
#	O
Autoimmune	O
hepatitis	O
s/p	O
liver	O
transplant:	O
Immunosupression	O
with	O
prednisone,	O
Imuran,	O
and	O
tacrolimus	O
was	O
continued.	O
Patient	O
had	O
one	O
dose	O
of	O
tacrolimus	O
held	O
on	O
day	O
of	O
admission	O
secondary	O
to	O
elevated	O
level	O
as	O
an	O
outpatient.	O
She	O
was	O
then	O
put	O
on	O
3.5	O
mg	O
q	O
12	O
hrs	O
and	O
level	O
in	O
house	O
of	O
8.7.	O
Her	O
prednisone	O
level	O
was	O
increased	O
to	O
10mg	O
daily	O
from	O
5	O
mg	O
daily	O
given	O
fatigue.	O
#	O
Hypertension:	O
Home	O
metoprolol,	O
amlodipine	O
were	O
continued.	O
Lisinopril	O
was	O
discontinued	O
in	O
setting	O
of	O
hyperkalemia	O
and	O
acute	O
on	O
chronic	O
kidney	O
disease.	O
She	O
was	O
additionally	O
started	O
on	O
HCTZ	O
25	O
mg	O
daily.	O
#	O
Hypertrygliceridemia:	O
continue	O
gemfibrozil	O
#	O
h/o	O
herpes	O
zoster:	O
continue	O
valacyclovir	O
(to	O
complete	O
total	O
course	O
of	O
3	O
months	O
per	O
ID).	O
continue	O
gabapentin.	O
#	O
Depression:	O
continue	O
zoloft	O
Transitional	O
Issues:	O
-	O
pt	O
will	O
follow	O
up	O
with	O
liver	O
transplant	O
clinic	O
re:	O
further	O
trending	O
of	O
tacrolimus	O
level	O
and	O
decreasing	O
prednisone	O
back	O
to	O
5	O
mg	O
daily.	O
-	O
will	O
need	O
to	O
follow	O
up	O
with	O
PCP	O
___:	O
management	O
of	O
hypertension	O
and	O
follow	O
up	O
of	O
toleration	O
of	O
medication	O
changes.	O
-	O
will	O
need	O
repeat	O
Chem-7	O
for	O
resolution	O
of	O
hyperkalemia.	O
Medications	O
on	O
Admission:	O
Preadmission	O
medications	O
listed	O
are	O
correct	O
and	O
complete.	O
Information	O
was	O
obtained	O
from	O
PatientPharmacy.	O
1.	O
Lantus	O
*NF*	O
(insulin	O
glargine)	O
100	O
unit/mL	O
Subcutaneous	O
daily	O
9	O
units	O
at	O
night	O
2.	O
Metoprolol	O
Succinate	O
XL	O
100	O
mg	O
PO	O
DAILY	O
3.	O
Amlodipine	O
10	O
mg	O
PO	O
DAILY	O
4.	O
Gemfibrozil	O
600	O
mg	O
PO	O
BID	O
5.	O
Lisinopril	O
10	O
mg	O
PO	O
DAILY	O
6.	O
Gabapentin	O
600	O
mg	O
PO	O
BID	O
7.	O
Tacrolimus	O
4.5	O
mg	O
PO	O
Q12H	O
8.	O
Ranitidine	O
300	O
mg	O
PO	O
DAILY	O
9.	O
CloniDINE	O
0.1	O
mg	O
PO	O
DAILY	O
10.	O
Sertraline	O
50	O
mg	O
PO	O
DAILY	O
11.	O
Zolpidem	O
Tartrate	O
5	O
mg	O
PO	O
HS	O
12.	O
ValACYclovir	O
500	O
mg	O
PO	O
Q24H	O
13.	O
Alendronate	O
Sodium	O
70	O
mg	O
PO	O
QWEEK	O
14.	O
Levothyroxine	O
Sodium	O
50	O
mcg	O
PO	O
DAILY	O
15.	O
Azathioprine	O
100	O
mg	O
PO	O
DAILY	O
16.	O
Ascorbic	O
Acid	O
___	O
mg	O
PO	O
BID	O
17.	O
PredniSONE	O
5	O
mg	O
PO	O
DAILY	O
18.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Amlodipine	O
10	O
mg	O
PO	O
DAILY	O
2.	O
Ascorbic	O
Acid	O
___	O
mg	O
PO	O
BID	O
3.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
4.	O
Azathioprine	O
100	O
mg	O
PO	O
DAILY	O
5.	O
CloniDINE	O
0.1	O
mg	O
PO	O
DAILY	O
6.	O
Gabapentin	O
600	O
mg	O
PO	O
BID	O
7.	O
Gemfibrozil	O
600	O
mg	O
PO	O
BID	O
8.	O
Levothyroxine	O
Sodium	O
50	O
mcg	O
PO	O
DAILY	O
9.	O
Metoprolol	O
Succinate	O
XL	O
100	O
mg	O
PO	O
DAILY	O
10.	O
PredniSONE	O
10	O
mg	O
PO	O
DAILY	O
RX	O
*prednisone	O
10	O
mg	O
1	O
tablets(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
11.	O
Ranitidine	O
300	O
mg	O
PO	O
DAILY	O
12.	O
Sertraline	O
50	O
mg	O
PO	O
DAILY	O
13.	O
Tacrolimus	O
3.5	O
mg	O
PO	O
Q12H	O
RX	O
*tacrolimus	O
[Prograf]	O
0.5	O
mg	O
one	O
capsule(s)	O
by	O
mouth	O
twice	O
daily	O
Disp	O
#*60	O
Capsule	O
Refills:*0	O
14.	O
ValACYclovir	O
500	O
mg	O
PO	O
Q24H	O
15.	O
Zolpidem	O
Tartrate	O
5	O
mg	O
PO	O
HS	O
16.	O
Hydrochlorothiazide	O
25	O
mg	O
PO	O
DAILY	O
RX	O
*hydrochlorothiazide	O
25	O
mg	O
one	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
17.	O
Alendronate	O
Sodium	O
70	O
mg	O
PO	O
QWEEK	O
18.	O
Lantus	O
*NF*	O
(insulin	O
glargine)	O
100	O
unit/mL	O
SUBCUTANEOUS	O
DAILY	O
9	O
units	O
at	O
night	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Hyperkalemia	O
Acute	O
on	O
Chronic	O
Renal	O
Insufficency	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Ms.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
because	O
your	O
outpatient	O
lab	O
work	O
showed	O
an	O
elevated	O
potassium.	O
You	O
recently	O
started	O
lisinopril	O
and	O
this	O
likely	O
contributed	O
to	O
your	O
elevated	O
potassium	O
level.	O
We	O
stopped	O
this	O
medication.	O
We	O
also	O
treated	O
you	O
with	O
kayexalate	O
to	O
bring	O
your	O
potassium	O
level	O
and	O
it	O
improved.	O
We	O
also	O
started	O
you	O
on	O
HCTZ	O
to	O
help	O
control	O
your	O
blood	O
pressure	O
since	O
we	O
stopped	O
your	O
lisinopril.	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you,	O
Your	O
BI	O
doctors	O
___	O
Instructions:	O
___	O

